Abstract:Depression is associated with immune dysregulation and the aberrant activity of the hypothalamic-pituitary-adrenal (HPA) axis. However, the neurobiological molecular mechanisms underlying these associations remain unclear. c-Jun amino-terminal kinase (JNK), an important modulator in inflammation and stress responses, is often critically implicated in the development of central nervous system diseases. However, whether and how JNK mediates neuroinflammation-induced depression remains largely unknown. In this study, we investigated the role of JNK in depressive-like behaviors induced by central lipopolysaccharide (LPS) infusion. The results showed that LPS infusion led to depressive-like behaviors, accompanied by increased proinflammatory cytokine expression, increased JNK activation, and upregulated glucocorticoid receptor (GR) phosphorylation at serine 246 (pGR-Ser246) in the habenula (Hb), amygdala (Amyg) and medial prefrontal cortex (mPFC). Treatment with SP600125, a known JNK inhibitor, prevented the LPS-induced hyper-activation of JNK and alleviated depressive-like behaviors. Moreover, LPS-induced increases in the expression levels of TNF-α, IL-1β and pGR-Ser246 in these brain regions were reduced when the rats were treated with SP600125. Our results show, for the first time, that JNK activities in the Hb, Amyg, and mPFC are involved in the modulation of neuroinflammation-induced depression and participate in the regulation of the expression of proinflammatory cytokines and GR phosphorylation, which are pathological factors associated with depression. Our findings provide new insights into the mechanism of neuroinflammation-associated depression and suggest that the JNK pathway may be a potential target for treating inflammation-related depression.

The mediation of immune activation on serotonin and glutamate systems in pathological process of depression

Affective Immunology: The Crosstalk Between Microglia and Astrocytes Plays Key Role?

Microglia Sing the Prelude of Neuroinflammation-Associated Depression

Inflammatory mediators in major depression and bipolar disorder

Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression

Brain-immune crosstalk in the treatment of major depressive disorder

Immunotherapy for depression: Recent insights and future targets

Involvement of Innate and Adaptive Immune Systems Alterations in the Pathophysiology and Treatment of Depression

Altered N-linked glycosylation in depression: A pre-clinical study

Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities

Novel insight into astrocyte-mediated gliotransmission modulates the synaptic plasticity in major depressive disorder

Stress induced microglial activation contributes to depression

Microglia in depression: current perspectives

The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes

Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis

Inhibition of JNK ameliorates depressive-like behaviors and reduces the activation of pro-inflammatory cytokines and the phosphorylation of glucocorticoid receptors at serine 246 induced by neuroinflammation

HMGB1 in depression: An overview of microglial HMBG1 in the pathogenesis of depression

Microglia Polarization and Endoplasmic Reticulum Stress in Chronic Social Defeat Stress Induced Depression Mouse

Inflammatory cytokines in depression: Neurobiological mechanisms and therapeutic implications

IL-1R/C3aR signaling regulates synaptic pruning in the prefrontal cortex of depression

The glutamatergic system in the development of stress-induced depression